139 Additionally, GLP-1RAs have been shown to enhance motor function and prolong survival in amyotrophic lateral sclerosis models, reduce neuronal degeneration, improve behavioral outcomes in Huntingtons disease models, and confer neuroprotection following traumatic brain injury and stroke by mitigating inflammation, reducing cerebral edema, and promoting neurological recovery
As a result, these drugs can help lower blood sugar and support weight loss
Overview on the effects of N-acetylcysteine in neurodegenerative diseases
GLP-1 medications (such as semaglutide, sold under brand names like Ozempic and Wegovy) have gained remarkable attention for their ability to help people shed unwanted pounds by curbing appetite and improving blood sugar balance
Among individuals with preexisting DR, GLP-1 RAs were not associated with progression to PDR and new-onset DME but associated with reduced incidence of vitreous hemorrhage and neovascular glaucoma